Breastfeeding associated with a reduced risk of relapse in women with multiple sclerosis – Women with multiple sclerosis who breastfeed exclusively for at least two months appear less likely to experience a relapse within a year after their baby’s birth, according to a report that will appear in the August print issue of Archives of Neurology, one of the JAMA/Archives journals.
Prescribing sunshine for multiple sclerosis? — Encouraging patients with multiple sclerosis to spend more time in the sun – might be a cheap and easy treatment. – Could a holiday in the sun reduce the risk of developing multiple sclerosis? In a recent review for F1000 Medicine Reports, Bridget Bagert and Dennis Bourdette highlight recent advances in potential treatments.
Acorda Therapeutics Announces FDA Acceptance of Fampridine-SR New Drug Application for Filing. FDA Assigns Priority Review and PDUFA Date of October_22, 2009. – Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced that the U.S. Food and Drug Administration (FDA) has accepted the Fampridine-SR New Drug Application (NDA) for filing, assigning Priority Review and a Prescription Drug User Fee Act (PDUFA) date of October_22, 2009.
New pill to treat MS – cladribine will be the first licensed treatment for MS which does not involve regular injections. – A new drug for multiple sclerosis can dramatically reduce the chances of a relapse or a deterioration of the condition, according to a new study from researchers at Queen Mary, University of London.
Stem cells from fat tissue offer hope for Multiple sclerosis MS treatment. – A preliminary study on the use of stem cells obtained from a patient’s own adipose tissue in the treatment of multiple sclerosis (MS) has shown promising results.
Genetic study shows direct link between vitamin D and MS susceptibility ‘gene’ – Researchers have found evidence that a direct interaction between vitamin D and a common genetic variant alters the risk of developing multiple sclerosis (MS).
If Brain MRI shows signs of Multiple sclerosis (MS), will the disease develop? – With more and more people having brain MRIs for various reasons, doctors are finding people whose scans show signs of multiple sclerosis (MS) even though they have no symptoms of the disease.
Research indicates drug alemtuzumab not only stops the Multiple sclerosis disease from advancing but may also restore lost function in many Multiple sclerosis patients. – A drug which was developed in Cambridge and initially designed to treat a form of leukaemia has also proven effective against combating the debilitating neurological disease multiple sclerosis (MS).
Smoking marijuana can have a harmful effect on the cognitive skills of people with multiple sclerosis (MS). – People with multiple sclerosis (MS) who smoke marijuana are more likely to have emotional and memory problems, according to research published February 13, 2008, in the online edition of Neurology, the medical journal of the American Academy of Neurology.
Genentech Inc. and Biogen Idec Inc.’s cancer drug Rituxan (rituximab) reduced brain lesions in multiple sclerosis patients. – A drug therapy, using rituximab, dramatically reduced the number of inflammatory lesions that form along nerve fibers in brains of multiple sclerosis patients, revealed by researchers recently.